Portal de Periódicos da CAPES

Antheia raises funds for drugs from yeast

2021; American Chemical Society; Volume: 99; Issue: 25 Linguagem: Inglês

10.1021/cen-09925-buscon14

2474-7408

Ryan Cross,

Biotechnology and Related Fields

Antheia, a synthetic biology company cofounded and led by Stanford University bioengineer Christina Smolke, has raised $73 million in series B financing. The start-up is based on Smolke's synthetic biology techniques for reprogramming yeast cells to produce complex molecules through fermentation rather than isolating them from plants. Her Stanford lab has engineered yeast to create drugs for cancer, neuromuscular disease, and pain. Antheia will initially focus on making drugs for cough, depression, opioid addiction, and pain.